首页 > 最新文献

Medical Care最新文献

英文 中文
Leveraging Electronic Health Records to Assess Residential Mobility Among Veterans in the Veterans Health Administration. 利用电子健康记录评估退伍军人健康管理局退伍军人的居住流动性。
IF 3 2区 医学 Q1 Medicine Pub Date : 2024-07-01 Epub Date: 2024-06-07 DOI: 10.1097/MLR.0000000000002017
Karen H Wang, Zoé M Hendrickson, Mary L Miller, Erica A Abel, Melissa Skanderson, Joseph Erdos, Julie A Womack, Cynthia A Brandt, Mayur Desai, Ling Han

Background: Residential mobility, or a change in residence, can influence health care utilization and outcomes. Health systems can leverage their patients' residential addresses stored in their electronic health records (EHRs) to better understand the relationships among patients' residences, mobility, and health. The Veteran Health Administration (VHA), with a unique nationwide network of health care systems and integrated EHR, holds greater potential for examining these relationships.

Methods: We conducted a cross-sectional analysis to examine the association of sociodemographics, clinical conditions, and residential mobility. We defined residential mobility by the number of VHA EHR residential addresses identified for each patient in a 1-year period (1/1-12/31/2018), with 2 different addresses indicating one move. We used generalized logistic regression to model the relationship between a priori selected correlates and residential mobility as a multinomial outcome (0, 1, ≥2 moves).

Results: In our sample, 84.4% (n=3,803,475) veterans had no move, 13.0% (n=587,765) had 1 move, and 2.6% (n=117,680) had ≥2 moves. In the multivariable analyses, women had greater odds of moving [aOR=1.11 (95% CI: 1.10,1.12) 1 move; 1.27 (1.25,1.30) ≥2 moves] than men. Veterans with substance use disorders also had greater odds of moving [aOR=1.26 (1.24,1.28) 1 move; 1.77 (1.72,1.81) ≥2 moves].

Discussion: Our study suggests about 16% of veterans seen at VHA had at least 1 residential move in 2018. VHA data can be a resource to examine relationships between place, residential mobility, and health.

背景:居住地的流动性或居住地的改变会影响医疗保健的使用和结果。医疗系统可以利用其电子健康记录(EHR)中存储的患者住址,更好地了解患者住址、流动性和健康之间的关系。退伍军人健康管理局(VHA)拥有独特的全国性医疗保健系统网络和综合电子病历,在研究这些关系方面具有更大的潜力:我们进行了一项横断面分析,以研究社会人口统计学、临床状况和居住流动性之间的关联。我们根据每位患者在 1 年内(1/1-12/31/2018)的 VHA EHR 住址数量来定义居住流动性,2 个不同的住址表示一次流动。我们使用广义逻辑回归来模拟先验选定的相关因素与居住流动性之间的关系,并将其作为多项式结果(0,1,≥2 次搬迁):在我们的样本中,84.4%(n=3,803,475)的退伍军人没有迁移过,13.0%(n=587,765)迁移过 1 次,2.6%(n=117,680)迁移≥2 次。在多变量分析中,女性搬家的几率比男性大[aOR=1.11 (95% CI: 1.10,1.12) 1次搬家;1.27 (1.25,1.30) ≥2次搬家]。患有药物使用障碍的退伍军人搬家的几率也更大[aOR=1.26 (1.24,1.28) 1次搬家;1.77 (1.72,1.81) ≥2次搬家]:我们的研究表明,2018 年,在退伍军人事务部就诊的退伍军人中约有 16% 的人至少搬过一次家。退伍军人事务部的数据可以成为研究地点、居住流动性和健康之间关系的资源。
{"title":"Leveraging Electronic Health Records to Assess Residential Mobility Among Veterans in the Veterans Health Administration.","authors":"Karen H Wang, Zoé M Hendrickson, Mary L Miller, Erica A Abel, Melissa Skanderson, Joseph Erdos, Julie A Womack, Cynthia A Brandt, Mayur Desai, Ling Han","doi":"10.1097/MLR.0000000000002017","DOIUrl":"https://doi.org/10.1097/MLR.0000000000002017","url":null,"abstract":"<p><strong>Background: </strong>Residential mobility, or a change in residence, can influence health care utilization and outcomes. Health systems can leverage their patients' residential addresses stored in their electronic health records (EHRs) to better understand the relationships among patients' residences, mobility, and health. The Veteran Health Administration (VHA), with a unique nationwide network of health care systems and integrated EHR, holds greater potential for examining these relationships.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis to examine the association of sociodemographics, clinical conditions, and residential mobility. We defined residential mobility by the number of VHA EHR residential addresses identified for each patient in a 1-year period (1/1-12/31/2018), with 2 different addresses indicating one move. We used generalized logistic regression to model the relationship between a priori selected correlates and residential mobility as a multinomial outcome (0, 1, ≥2 moves).</p><p><strong>Results: </strong>In our sample, 84.4% (n=3,803,475) veterans had no move, 13.0% (n=587,765) had 1 move, and 2.6% (n=117,680) had ≥2 moves. In the multivariable analyses, women had greater odds of moving [aOR=1.11 (95% CI: 1.10,1.12) 1 move; 1.27 (1.25,1.30) ≥2 moves] than men. Veterans with substance use disorders also had greater odds of moving [aOR=1.26 (1.24,1.28) 1 move; 1.77 (1.72,1.81) ≥2 moves].</p><p><strong>Discussion: </strong>Our study suggests about 16% of veterans seen at VHA had at least 1 residential move in 2018. VHA data can be a resource to examine relationships between place, residential mobility, and health.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Call for Action to Target Interhospital Variation in Cardiovascular Mortality, Readmissions, and Length-of-Stay: Results of a National Population Analysis. 针对医院间心血管死亡率、再入院率和住院时间差异的行动呼吁:全国人口分析结果。
IF 3 2区 医学 Q1 Medicine Pub Date : 2024-07-01 Epub Date: 2024-05-21 DOI: 10.1097/MLR.0000000000002012
Astrid Van Wilder, Luk Bruyneel, Bianca Cox, Fien Claessens, Dirk De Ridder, Stefan Janssens, Kris Vanhaecht

Background: Excessive interhospital variation threatens healthcare quality. Data on variation in patient outcomes across the whole cardiovascular spectrum are lacking. We aimed to examine interhospital variability for 28 cardiovascular All Patient Refined-Diagnosis-related Groups (APR-DRGs).

Methods: We studied 103,299 cardiovascular admissions in 99 (98%) Belgian acute-care hospitals between 2012 and 2018. Using generalized linear mixed models, we estimated hospital-specific and APR-DRG-specific risk-standardized rates for in-hospital mortality, 30-day readmissions, and length-of-stay above the APR-DRG-specific 90th percentile. Interhospital variation was assessed based on estimated variance components and time trends between the 2012-2014 and 2016-2018 periods were examined.

Results: There was strong evidence of interhospital variation, with statistically significant variation across the 3 outcomes for 5 APR-DRGs after accounting for patient and hospital factors: percutaneous cardiovascular procedures with acute myocardial infarction, heart failure, hypertension, angina pectoris, and arrhythmia. Medical diagnoses, with in particular hypertension, heart failure, angina pectoris, and cardiac arrest, showed strongest variability, with hypertension displaying the largest median odds ratio for mortality (2.51). Overall, hospitals performing at the upper-quartile level should achieve improvements to the median level, and an annual 633 deaths, 322 readmissions, and 1578 extended hospital stays could potentially be avoided.

Conclusions: Analysis of interhospital variation highlights important outcome differences that are not explained by known patient or hospital characteristics. Targeting variation is therefore a promising strategy to improve cardiovascular care. Considering their treatment in multidisciplinary teams, policy makers, and managers should prioritize heart failure, hypertension, cardiac arrest, and angina pectoris improvements by targeting guideline implementation outside the cardiology department.

背景:医院间的过度差异威胁着医疗质量。目前还缺乏有关整个心血管领域患者预后差异的数据。我们旨在研究 28 个心血管疾病所有患者精制诊断相关分组(APR-DRGs)的医院间差异:我们研究了 2012 年至 2018 年期间 99 家(98%)比利时急诊医院的 103,299 例心血管入院患者。使用广义线性混合模型,我们估算了医院特异性和APR-DRG特异性院内死亡率、30天再入院率和住院时间超过APR-DRG特异性第90百分位数的风险标准化率。根据估计的方差成分对医院间差异进行了评估,并研究了2012-2014年和2016-2018年期间的时间趋势:在考虑了患者和医院因素后,有确凿证据表明医院间存在差异,5 个 APR-DRGs 的 3 种结果在统计学上存在显著差异:急性心肌梗死经皮心血管手术、心力衰竭、高血压、心绞痛和心律失常。医疗诊断,尤其是高血压、心力衰竭、心绞痛和心脏骤停显示出最大的变异性,其中高血压显示出最大的死亡率中位数比值(2.51)。总体而言,表现在上四分位数水平的医院应能达到中位数水平,每年可避免633例死亡、322例再入院和1578例延长住院时间:对医院间差异的分析凸显了一些重要的结果差异,这些差异无法用已知的患者或医院特征来解释。因此,针对差异是改善心血管病治疗的一个很有前景的策略。考虑到他们在多学科团队中的治疗,决策者和管理者应优先考虑改善心衰、高血压、心脏骤停和心绞痛的治疗,在心内科以外的科室有针对性地实施指南。
{"title":"Call for Action to Target Interhospital Variation in Cardiovascular Mortality, Readmissions, and Length-of-Stay: Results of a National Population Analysis.","authors":"Astrid Van Wilder, Luk Bruyneel, Bianca Cox, Fien Claessens, Dirk De Ridder, Stefan Janssens, Kris Vanhaecht","doi":"10.1097/MLR.0000000000002012","DOIUrl":"10.1097/MLR.0000000000002012","url":null,"abstract":"<p><strong>Background: </strong>Excessive interhospital variation threatens healthcare quality. Data on variation in patient outcomes across the whole cardiovascular spectrum are lacking. We aimed to examine interhospital variability for 28 cardiovascular All Patient Refined-Diagnosis-related Groups (APR-DRGs).</p><p><strong>Methods: </strong>We studied 103,299 cardiovascular admissions in 99 (98%) Belgian acute-care hospitals between 2012 and 2018. Using generalized linear mixed models, we estimated hospital-specific and APR-DRG-specific risk-standardized rates for in-hospital mortality, 30-day readmissions, and length-of-stay above the APR-DRG-specific 90th percentile. Interhospital variation was assessed based on estimated variance components and time trends between the 2012-2014 and 2016-2018 periods were examined.</p><p><strong>Results: </strong>There was strong evidence of interhospital variation, with statistically significant variation across the 3 outcomes for 5 APR-DRGs after accounting for patient and hospital factors: percutaneous cardiovascular procedures with acute myocardial infarction, heart failure, hypertension, angina pectoris, and arrhythmia. Medical diagnoses, with in particular hypertension, heart failure, angina pectoris, and cardiac arrest, showed strongest variability, with hypertension displaying the largest median odds ratio for mortality (2.51). Overall, hospitals performing at the upper-quartile level should achieve improvements to the median level, and an annual 633 deaths, 322 readmissions, and 1578 extended hospital stays could potentially be avoided.</p><p><strong>Conclusions: </strong>Analysis of interhospital variation highlights important outcome differences that are not explained by known patient or hospital characteristics. Targeting variation is therefore a promising strategy to improve cardiovascular care. Considering their treatment in multidisciplinary teams, policy makers, and managers should prioritize heart failure, hypertension, cardiac arrest, and angina pectoris improvements by targeting guideline implementation outside the cardiology department.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141075879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Heterogeneity in Cost-Effectiveness Using Machine Learning Methods: A Case Study Using the FIRST-ABC Trial. 利用机器学习方法探索成本效益的异质性:使用 FIRST-ABC 试验的案例研究。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-01 Epub Date: 2024-06-07 DOI: 10.1097/MLR.0000000000002010
Zaid Hattab, Edel Doherty, Zia Sadique, Padmanabhan Ramnarayan, Stephen O'Neill

Objective: The aim of this study was to explore heterogeneity in the cost-effectiveness of high-flow nasal cannula (HFNC) therapy compared with continuous positive airway pressure (CPAP) in children following extubation.

Design: Using data from the FIRST-line support for Assistance in Breathing in Children (FIRST-ABC) trial, we explore heterogeneity at the individual and subgroup levels using a causal forest approach, alongside a seemingly unrelated regression (SUR) approach for comparison.

Settings: FIRST-ABC is a noninferiority randomized controlled trial (ISRCTN60048867) including children in UK paediatric intensive care units, which compared HFNC with CPAP as the first-line mode of noninvasive respiratory support.

Patients: In the step-down FIRST-ABC, 600 children clinically assessed to require noninvasive respiratory support were randomly assigned to HFNC and CPAP groups with 1:1 treatment allocation ratio. In this analysis, 118 patients were excluded because they did not consent to accessing their medical records, did not consent to follow-up questionnaire or did not receive respiratory support.

Measurements and main results: The primary outcome of this study is the incremental net monetary benefit (INB) of HFNC compared with CPAP using a willingness-to-pay threshold of £20,000 per QALY gain. INB is calculated based on total costs and quality adjusted life years (QALYs) at 6 months. The findings suggest modest heterogeneity in cost-effectiveness of HFNC compared with CPAP at the subgroup level, while greater heterogeneity is detected at the individual level.

Conclusions: The estimated overall INB of HFNC is smaller than the INB for patients with better baseline status suggesting that HFNC can be more cost-effective among less severely ill patients.

目的本研究旨在探讨儿童拔管后高流量鼻插管(HFNC)疗法与持续气道正压(CPAP)疗法成本效益的异质性:设计:利用儿童呼吸辅助系统 FIRST-ABC(FIRST-line support for Assistance in Breathing in Children,FIRST-ABC)试验的数据,我们采用因果森林法探讨了个体和亚组水平的异质性,同时还采用了看似不相关的回归法(SUR)进行比较:FIRST-ABC 是一项非劣效性随机对照试验(ISRCTN60048867),试验对象包括英国儿科重症监护病房的儿童,该试验比较了 HFNC 和 CPAP 作为无创呼吸支持的一线模式:在降级 FIRST-ABC 中,600 名临床评估为需要无创呼吸支持的儿童以 1:1 的治疗分配比例被随机分配到 HFNC 组和 CPAP 组。在本次分析中,有 118 名患者因不同意查阅病历、不同意接受随访问卷或未接受呼吸支持而被排除在外:本研究的主要结果是高频NC与CPAP相比的增量净货币效益(INB),以每QALY收益20,000英镑为支付意愿阈值。INB 根据总成本和 6 个月的质量调整生命年 (QALY) 计算。研究结果表明,与 CPAP 相比,HFNC 的成本效益在亚组水平上存在适度的异质性,而在个体水平上则存在更大的异质性:HFNC的估计总体INB小于基线状况较好的患者的INB,这表明HFNC在病情较轻的患者中更具成本效益。
{"title":"Exploring Heterogeneity in Cost-Effectiveness Using Machine Learning Methods: A Case Study Using the FIRST-ABC Trial.","authors":"Zaid Hattab, Edel Doherty, Zia Sadique, Padmanabhan Ramnarayan, Stephen O'Neill","doi":"10.1097/MLR.0000000000002010","DOIUrl":"10.1097/MLR.0000000000002010","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to explore heterogeneity in the cost-effectiveness of high-flow nasal cannula (HFNC) therapy compared with continuous positive airway pressure (CPAP) in children following extubation.</p><p><strong>Design: </strong>Using data from the FIRST-line support for Assistance in Breathing in Children (FIRST-ABC) trial, we explore heterogeneity at the individual and subgroup levels using a causal forest approach, alongside a seemingly unrelated regression (SUR) approach for comparison.</p><p><strong>Settings: </strong>FIRST-ABC is a noninferiority randomized controlled trial (ISRCTN60048867) including children in UK paediatric intensive care units, which compared HFNC with CPAP as the first-line mode of noninvasive respiratory support.</p><p><strong>Patients: </strong>In the step-down FIRST-ABC, 600 children clinically assessed to require noninvasive respiratory support were randomly assigned to HFNC and CPAP groups with 1:1 treatment allocation ratio. In this analysis, 118 patients were excluded because they did not consent to accessing their medical records, did not consent to follow-up questionnaire or did not receive respiratory support.</p><p><strong>Measurements and main results: </strong>The primary outcome of this study is the incremental net monetary benefit (INB) of HFNC compared with CPAP using a willingness-to-pay threshold of £20,000 per QALY gain. INB is calculated based on total costs and quality adjusted life years (QALYs) at 6 months. The findings suggest modest heterogeneity in cost-effectiveness of HFNC compared with CPAP at the subgroup level, while greater heterogeneity is detected at the individual level.</p><p><strong>Conclusions: </strong>The estimated overall INB of HFNC is smaller than the INB for patients with better baseline status suggesting that HFNC can be more cost-effective among less severely ill patients.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variation in Time-to-Gender-Affirming Hormone Therapy in US Active Duty Service Members. 美国现役军人接受性别确认激素治疗的时间差异。
IF 3 2区 医学 Q1 Medicine Pub Date : 2024-07-01 Epub Date: 2024-05-16 DOI: 10.1097/MLR.0000000000002011
David A Klein, Xenia B Gonzalez, Krista B Highland, Jennifer A Thornton, Kevin W Sunderland, Wendy Funk, Veronika Pav, Rick Brydum, Natasha A Schvey, Christina M Roberts

Background: Beginning in July 2016, transgender service members in the US military were allowed to receive gender-affirming medical care, if so desired.

Objective: This study aimed to evaluate variation in time-to-hormone therapy initiation in active duty Service members after the receipt of a diagnosis indicative of gender dysphoria in the Military Health System.

Research design: This retrospective cohort study included data from those enrolled in TRICARE Prime between July 2016 and December 2021 and extracted from the Military Health System Data Repository.

Participants: A population-based sample of US Service members who had an encounter with a relevant International Classification of Diseases 9/10 diagnosis code.

Measures: Time-to-gender-affirming hormone initiation after diagnosis receipt.

Results: A total of 2439 Service members were included (M age 24 y; 62% white, 16% Black; 12% Latine; 65% Junior Enlisted; 37% Army, 29% Navy, 25% Air Force, 7% Marine Corps; 46% first recorded administrative assigned gender marker female). Overall, 41% and 52% initiated gender-affirming hormone therapy within 1 and 3 years of diagnosis, respectively. In the generalized additive model, time-to-gender-affirming hormone initiation was longer for Service members with a first administrative assigned gender marker of male relative to female ( P <0.001), and Asian and Pacific Islander ( P =0.02) and Black ( P =0.047) relative to white Service members. In time-varying interactions, junior enlisted members had longer time-to-initiation, relative to senior enlisted members and junior officers, until about 2-years postinitial diagnosis.

Conclusion: The significant variation and documented inequities indicate that institutional data-driven policy modifications are needed to ensure timely access for those desiring care.

背景:自 2016 年 7 月起,美国军队中的变性军人可根据需要接受性别确认医疗服务:本研究旨在评估现役军人在军队医疗系统中被诊断出患有性别障碍后开始接受激素治疗的时间差异:这项回顾性队列研究包括2016年7月至2021年12月期间加入TRICARE Prime的人员数据,这些数据提取自军事卫生系统数据存储库:以人口为基础的美国现役军人样本,他们曾遇到过相关的国际疾病分类 9/10 诊断代码:结果:共有 2439 名现役军人接受了性别确认激素治疗:共纳入 2439 名军人(年龄 24 岁;62% 为白人,16% 为黑人;12% 为拉丁人种;65% 为初级军人;37% 为陆军,29% 为海军,25% 为空军,7% 为海军陆战队;46% 首次记录的行政分配性别标记为女性)。总体而言,分别有 41% 和 52% 的人在确诊后 1 年和 3 年内开始接受确认性别的激素治疗。在广义相加模型中,首次行政分配性别标记为男性的军人开始接受性别确认激素治疗的时间要长于女性(PC结论:巨大的差异和记录在案的不平等表明,需要以机构数据为导向修改政策,以确保那些希望获得治疗的人能够及时获得治疗。
{"title":"Variation in Time-to-Gender-Affirming Hormone Therapy in US Active Duty Service Members.","authors":"David A Klein, Xenia B Gonzalez, Krista B Highland, Jennifer A Thornton, Kevin W Sunderland, Wendy Funk, Veronika Pav, Rick Brydum, Natasha A Schvey, Christina M Roberts","doi":"10.1097/MLR.0000000000002011","DOIUrl":"10.1097/MLR.0000000000002011","url":null,"abstract":"<p><strong>Background: </strong>Beginning in July 2016, transgender service members in the US military were allowed to receive gender-affirming medical care, if so desired.</p><p><strong>Objective: </strong>This study aimed to evaluate variation in time-to-hormone therapy initiation in active duty Service members after the receipt of a diagnosis indicative of gender dysphoria in the Military Health System.</p><p><strong>Research design: </strong>This retrospective cohort study included data from those enrolled in TRICARE Prime between July 2016 and December 2021 and extracted from the Military Health System Data Repository.</p><p><strong>Participants: </strong>A population-based sample of US Service members who had an encounter with a relevant International Classification of Diseases 9/10 diagnosis code.</p><p><strong>Measures: </strong>Time-to-gender-affirming hormone initiation after diagnosis receipt.</p><p><strong>Results: </strong>A total of 2439 Service members were included (M age 24 y; 62% white, 16% Black; 12% Latine; 65% Junior Enlisted; 37% Army, 29% Navy, 25% Air Force, 7% Marine Corps; 46% first recorded administrative assigned gender marker female). Overall, 41% and 52% initiated gender-affirming hormone therapy within 1 and 3 years of diagnosis, respectively. In the generalized additive model, time-to-gender-affirming hormone initiation was longer for Service members with a first administrative assigned gender marker of male relative to female ( P <0.001), and Asian and Pacific Islander ( P =0.02) and Black ( P =0.047) relative to white Service members. In time-varying interactions, junior enlisted members had longer time-to-initiation, relative to senior enlisted members and junior officers, until about 2-years postinitial diagnosis.</p><p><strong>Conclusion: </strong>The significant variation and documented inequities indicate that institutional data-driven policy modifications are needed to ensure timely access for those desiring care.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140958442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discussions of Cancer Survivorship Care Needs: Are There Rural Versus Urban Inequities? 癌症幸存者护理需求讨论:农村与城市之间是否存在不平等?
IF 3 2区 医学 Q1 Medicine Pub Date : 2024-07-01 Epub Date: 2024-05-21 DOI: 10.1097/MLR.0000000000002014
Tyrone F Borders, Lindsey Hammerslag

Background: Rural cancer survivors may face greater challenges receiving survivorship care than urban cancer survivors.

Purpose: To test for rural versus urban inequities and identify other correlates of discussions about cancer survivorship care with healthcare professionals.

Methods: Data are from the 2017 Medical Expenditure Panel Survey (MEPS), which included a cancer survivorship supplement. Adult survivors were asked if they discussed with a healthcare professional 5 components of survivorship care: need for follow-up services, lifestyle/health recommendations, emotional/social needs, long-term side effects, and a summary of treatments received. The Behavioral Model of Health Services guided the inclusion of predisposing, enabling, and need factors in ordered logit regression models of each survivorship care variable.

Results: A significantly lower proportion of rural than urban survivors (42% rural, 52% urban) discussed in detail the treatments they received, but this difference did not persist in the multivariable model. Although 69% of rural and 70% of urban ssurvivors discussed in detail their follow-up care needs, less than 50% of both rural and urban survivors discussed in detail other dimensions of survivorship care. Non-Hispanic Black race/ethnicity and time since treatment were associated with lower odds of discussing 3 or more dimensions of survivorship care.

Conclusions: This study found only a single rural/urban difference in discussions about survivorship care. With the exception of discussions about the need for follow-up care, rates of discussing in detail other dimensions of survivorship care were low among rural and urban survivors alike.

背景:与城市癌症幸存者相比,农村癌症幸存者在接受幸存者护理方面可能面临更大的挑战:目的:检验农村与城市之间的不平等,并确定与医疗保健专业人员讨论癌症幸存者护理的其他相关因素:数据来自2017年医疗支出小组调查(MEPS),其中包括癌症幸存者补充调查。成年幸存者被问及是否与医疗保健专业人员讨论过幸存者护理的 5 项内容:后续服务需求、生活方式/健康建议、情感/社会需求、长期副作用以及所接受治疗的总结。在健康服务行为模型的指导下,在每个幸存者护理变量的有序对数回归模型中纳入了易感因素、有利因素和需求因素:农村幸存者详细讨论所接受治疗的比例明显低于城市幸存者(农村为 42%,城市为 52%),但这一差异在多变量模型中并不存在。尽管69%的农村幸存者和70%的城市幸存者详细讨论了他们的后续护理需求,但只有不到50%的农村幸存者和城市幸存者详细讨论了幸存者护理的其他方面。非西班牙裔黑人种族/人种和治疗后时间与讨论 3 个或更多幸存者护理方面的几率较低有关:本研究发现,在有关幸存者护理的讨论中,城乡之间只有一个差异。除了关于后续护理需求的讨论外,农村和城市幸存者详细讨论幸存者护理其他方面的比率都很低。
{"title":"Discussions of Cancer Survivorship Care Needs: Are There Rural Versus Urban Inequities?","authors":"Tyrone F Borders, Lindsey Hammerslag","doi":"10.1097/MLR.0000000000002014","DOIUrl":"10.1097/MLR.0000000000002014","url":null,"abstract":"<p><strong>Background: </strong>Rural cancer survivors may face greater challenges receiving survivorship care than urban cancer survivors.</p><p><strong>Purpose: </strong>To test for rural versus urban inequities and identify other correlates of discussions about cancer survivorship care with healthcare professionals.</p><p><strong>Methods: </strong>Data are from the 2017 Medical Expenditure Panel Survey (MEPS), which included a cancer survivorship supplement. Adult survivors were asked if they discussed with a healthcare professional 5 components of survivorship care: need for follow-up services, lifestyle/health recommendations, emotional/social needs, long-term side effects, and a summary of treatments received. The Behavioral Model of Health Services guided the inclusion of predisposing, enabling, and need factors in ordered logit regression models of each survivorship care variable.</p><p><strong>Results: </strong>A significantly lower proportion of rural than urban survivors (42% rural, 52% urban) discussed in detail the treatments they received, but this difference did not persist in the multivariable model. Although 69% of rural and 70% of urban ssurvivors discussed in detail their follow-up care needs, less than 50% of both rural and urban survivors discussed in detail other dimensions of survivorship care. Non-Hispanic Black race/ethnicity and time since treatment were associated with lower odds of discussing 3 or more dimensions of survivorship care.</p><p><strong>Conclusions: </strong>This study found only a single rural/urban difference in discussions about survivorship care. With the exception of discussions about the need for follow-up care, rates of discussing in detail other dimensions of survivorship care were low among rural and urban survivors alike.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11155275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141076167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021. 2021 年美国在获得甲基苯丙胺戒毒服务方面的地域和种族/族裔差异。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-07-01 Epub Date: 2024-05-15 DOI: 10.1097/MLR.0000000000002013
George Pro, Jonathan Cantor, Mance Buttram, Clare C Brown, Mofan Gu, Michael Mancino, Nickolas Zaller

Introduction: Methamphetamine detoxification before entering formal and longer term treatment may have a positive impact on treatment retention and success. Understanding geographic distribution of methamphetamine specialty detox services and differential access by race/ethnicity is critical for establishing policies that ensure equitable access across populations.

Methods: We used the Mental health and Addiction Treatment Tracking Repository to identify treatment facilities that offered any substance use detoxification in 2021 (N=2346) as well as the census block group in which they were located. We sourced data from the US Census Bureau to identify the percentage of a census block group that was White, Black, and Hispanic. We used logistic regression to model the availability of methamphetamine-specific detox, predicted by the percentage of a block group that was Black and Hispanic. We adjusted for relevant covariates and defined state as a random effect. We calculated model-based predicted probabilities.

Results: Over half (60%) of detox facilities offered additional detox services specifically for methamphetamine. Sixteen states had <10 methamphetamine-specific detox facilities. The predicted probability of methamphetamine-specific detox availability was 60% in census block groups with 0%-9% Black residents versus only 46% in census block groups with 90%-100% Black residents, and was 61% in census block groups with 0%-9% Hispanic residents versus 30% in census block groups with 90%-100% Hispanic residents.

Conclusions: During an unprecedented national methamphetamine crisis, access to a critical health care service was disproportionately lower in communities that were predominately Black and Hispanic. We orient our findings around a discussion of health disparities, residential segregation, and the upstream causes of the systematic exclusion of minoritized communities from health care.

导言:在接受正式和长期治疗前进行甲基苯丙胺戒毒可能会对治疗的持续性和成功率产生积极影响。了解甲基苯丙胺专业戒毒服务的地理分布以及不同种族/人种获得服务的差异,对于制定确保不同人群公平获得服务的政策至关重要:我们使用精神健康和成瘾治疗跟踪库(Mental health and Addiction Treatment Tracking Repository)来确定 2021 年提供任何药物使用戒毒服务的治疗机构(N=2346)以及这些机构所在的人口普查区组。我们从美国人口普查局获取数据,以确定白人、黑人和西班牙裔在人口普查区组中所占的比例。我们使用逻辑回归法建立了一个模型,根据街区组中黑人和西班牙裔所占的比例来预测甲基苯丙胺专用戒毒所的可用性。我们对相关协变量进行了调整,并将州定义为随机效应。我们计算了基于模型的预测概率:超过一半(60%)的戒毒机构提供了专门针对甲基苯丙胺的额外戒毒服务。16个州得出了结论:在史无前例的全国甲基苯丙胺危机期间,黑人和西班牙裔占多数的社区获得关键医疗服务的比例过低。我们围绕健康差异、居住隔离以及系统性地将少数群体排除在医疗服务之外的上游原因展开讨论,从而得出结论。
{"title":"Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021.","authors":"George Pro, Jonathan Cantor, Mance Buttram, Clare C Brown, Mofan Gu, Michael Mancino, Nickolas Zaller","doi":"10.1097/MLR.0000000000002013","DOIUrl":"10.1097/MLR.0000000000002013","url":null,"abstract":"<p><strong>Introduction: </strong>Methamphetamine detoxification before entering formal and longer term treatment may have a positive impact on treatment retention and success. Understanding geographic distribution of methamphetamine specialty detox services and differential access by race/ethnicity is critical for establishing policies that ensure equitable access across populations.</p><p><strong>Methods: </strong>We used the Mental health and Addiction Treatment Tracking Repository to identify treatment facilities that offered any substance use detoxification in 2021 (N=2346) as well as the census block group in which they were located. We sourced data from the US Census Bureau to identify the percentage of a census block group that was White, Black, and Hispanic. We used logistic regression to model the availability of methamphetamine-specific detox, predicted by the percentage of a block group that was Black and Hispanic. We adjusted for relevant covariates and defined state as a random effect. We calculated model-based predicted probabilities.</p><p><strong>Results: </strong>Over half (60%) of detox facilities offered additional detox services specifically for methamphetamine. Sixteen states had <10 methamphetamine-specific detox facilities. The predicted probability of methamphetamine-specific detox availability was 60% in census block groups with 0%-9% Black residents versus only 46% in census block groups with 90%-100% Black residents, and was 61% in census block groups with 0%-9% Hispanic residents versus 30% in census block groups with 90%-100% Hispanic residents.</p><p><strong>Conclusions: </strong>During an unprecedented national methamphetamine crisis, access to a critical health care service was disproportionately lower in communities that were predominately Black and Hispanic. We orient our findings around a discussion of health disparities, residential segregation, and the upstream causes of the systematic exclusion of minoritized communities from health care.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140958441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increasing Health Equity Through Innovative Strategies: Addressing Health Disparities Among Adults With Limited English Proficiency. 通过创新战略增进健康公平:通过创新战略增进健康平等:解决英语水平有限的成年人中存在的健康差异。
IF 3 2区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-05-10 DOI: 10.1097/MLR.0000000000002006
Joanne L Calista
{"title":"Increasing Health Equity Through Innovative Strategies: Addressing Health Disparities Among Adults With Limited English Proficiency.","authors":"Joanne L Calista","doi":"10.1097/MLR.0000000000002006","DOIUrl":"https://doi.org/10.1097/MLR.0000000000002006","url":null,"abstract":"","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in HCAHPS Survey Scores, 2008-2019: A Quality Improvement Perspective. 2008-2019 年 HCAHPS 调查得分趋势:质量改进视角。
IF 3 2区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-04-12 DOI: 10.1097/MLR.0000000000002001
Megan K Beckett, Denise D Quigley, Christopher W Cohea, William G Lehrman, Chelsea Russ, Laura A Giordano, Elizabeth Goldstein, Marc N Elliott

Background: HCAHPS' 2008 initial public reporting, 2012 inclusion in the Hospital Value-Based Purchasing Program (HVBP), and 2015 inclusion in Hospital Star Ratings were intended to improve patient experiences.

Objectives: Characterize pre-COVID-19 (2008-2019) trends in hospital consumer assessment of healthcare providers and systems (HCAHPS) scores.

Research design: Describe HCAHPS score trends overall, by phase: (1) initial public reporting period (2008-2013), (2) first 2 years of HVBP (2013-2015), and (3) initial HCAHPS Star Ratings reporting (2015-2019); and by hospital characteristics (HCAHPS decile, ownership, size, teaching affiliation, and urban/rural).

Subjects: A total of 3909 HCAHPS-participating US hospitals.

Measures: HCAHPS summary score (HCAHPS-SS) and 9 measures.

Results: The mean 2007-2019 HCAHPS-SS improvement in most-positive-category ("top-box") responses was +5.2 percentage points/pp across all hospitals (where differences of 5pp, 3pp, and 1pp are "large," "medium," and "small"). Improvement rate was largest in phase 1 (+0.8/pp/year vs. +0.2pp/year and +0.1pp/year for phases 2 and 3, respectively). Improvement was largest for Overall Rating of Hospital (+8.5pp), Discharge Information (+7.3pp), and Nurse Communication (+6.5pp), smallest for Doctor Communication (+0.8pp). Some measures improved notably through phases 2 and 3 (Nurse Communication, Staff Responsiveness, Overall Rating of Hospital), but others slowed or reversed in Phase 3 (Communication about Medicines, Quietness). Bottom-decile hospitals improved more than other hospitals for all measures.

Conclusions: All HCAHPS measures improved rapidly 2008-2013, especially among low-performing (bottom-decile) hospitals, narrowing the range of performance and improving scores overall. This initial improvement may reflect widespread, general quality improvement (QI) efforts in lower-performing hospitals. Subsequent slower improvement following the introduction of HVBP and Star Ratings may have reflected targeted, resource-intensive QI in higher-performing hospitals.

背景:HCAHPS 于 2008 年首次公开报告,2012 年被纳入医院价值采购计划 (HVBP),2015 年被纳入医院星级评定,旨在改善患者体验:描述 COVID-19 前(2008-2019 年)医院消费者对医疗保健提供者和系统的评估(HCAHPS)得分趋势:研究设计:描述 HCAHPS 评分的整体趋势,按阶段划分:(1)最初的公开报告期(2008-2013 年),(2)HVBP 的前两年(2013-2015 年),(3)最初的 HCAHPS 星级评级报告(2015-2019 年);以及按医院特征(HCAHPS 十分位数、所有权、规模、教学附属机构和城市/农村)划分:共有 3909 家参与 HCAHPS 的美国医院:HCAHPS总分(HCAHPS-SS)和9项指标:所有医院 2007-2019 年 HCAHPS-SS 最积极类别("顶部方框")响应的平均改善率为 +5.2 个百分点/百分点(其中 5 个百分点、3 个百分点和 1 个百分点的差异为 "大"、"中 "和 "小")。第 1 阶段的改善幅度最大(+0.8 个百分点/年,第 2 和第 3 阶段分别为+0.2 个百分点/年和+0.1 个百分点/年)。医院总体评价(+8.5 个百分点)、出院信息(+7.3 个百分点)和护士沟通(+6.5 个百分点)的改善幅度最大,医生沟通(+0.8 个百分点)的改善幅度最小。一些指标在第二和第三阶段有显著改善(护士沟通、员工响应度、医院总体评价),但其他指标在第三阶段有所放缓或逆转(药品沟通、安静度)。在所有衡量标准中,排名倒数第 10 位的医院比其他医院进步更大:所有 HCAHPS 指标在 2008-2013 年间都得到了迅速改善,尤其是在表现较差的医院(倒数第 10 位)中,从而缩小了表现范围并提高了总体得分。最初的改善可能反映了表现较差的医院在质量改进(QI)方面的广泛努力。在引入 HVBP 和星级评定后,随后的改善速度放缓,这可能反映了绩效较高医院有针对性的、资源密集型 QI。
{"title":"Trends in HCAHPS Survey Scores, 2008-2019: A Quality Improvement Perspective.","authors":"Megan K Beckett, Denise D Quigley, Christopher W Cohea, William G Lehrman, Chelsea Russ, Laura A Giordano, Elizabeth Goldstein, Marc N Elliott","doi":"10.1097/MLR.0000000000002001","DOIUrl":"https://doi.org/10.1097/MLR.0000000000002001","url":null,"abstract":"<p><strong>Background: </strong>HCAHPS' 2008 initial public reporting, 2012 inclusion in the Hospital Value-Based Purchasing Program (HVBP), and 2015 inclusion in Hospital Star Ratings were intended to improve patient experiences.</p><p><strong>Objectives: </strong>Characterize pre-COVID-19 (2008-2019) trends in hospital consumer assessment of healthcare providers and systems (HCAHPS) scores.</p><p><strong>Research design: </strong>Describe HCAHPS score trends overall, by phase: (1) initial public reporting period (2008-2013), (2) first 2 years of HVBP (2013-2015), and (3) initial HCAHPS Star Ratings reporting (2015-2019); and by hospital characteristics (HCAHPS decile, ownership, size, teaching affiliation, and urban/rural).</p><p><strong>Subjects: </strong>A total of 3909 HCAHPS-participating US hospitals.</p><p><strong>Measures: </strong>HCAHPS summary score (HCAHPS-SS) and 9 measures.</p><p><strong>Results: </strong>The mean 2007-2019 HCAHPS-SS improvement in most-positive-category (\"top-box\") responses was +5.2 percentage points/pp across all hospitals (where differences of 5pp, 3pp, and 1pp are \"large,\" \"medium,\" and \"small\"). Improvement rate was largest in phase 1 (+0.8/pp/year vs. +0.2pp/year and +0.1pp/year for phases 2 and 3, respectively). Improvement was largest for Overall Rating of Hospital (+8.5pp), Discharge Information (+7.3pp), and Nurse Communication (+6.5pp), smallest for Doctor Communication (+0.8pp). Some measures improved notably through phases 2 and 3 (Nurse Communication, Staff Responsiveness, Overall Rating of Hospital), but others slowed or reversed in Phase 3 (Communication about Medicines, Quietness). Bottom-decile hospitals improved more than other hospitals for all measures.</p><p><strong>Conclusions: </strong>All HCAHPS measures improved rapidly 2008-2013, especially among low-performing (bottom-decile) hospitals, narrowing the range of performance and improving scores overall. This initial improvement may reflect widespread, general quality improvement (QI) efforts in lower-performing hospitals. Subsequent slower improvement following the introduction of HVBP and Star Ratings may have reflected targeted, resource-intensive QI in higher-performing hospitals.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Philadelphia Latine Immigrant Birthing People's Perspectives on Mitigating the Chilling Effect on Prenatal Care Utilization. 费城拉丁裔移民生育者对减轻产前护理使用寒蝉效应的看法。
IF 3.3 2区 医学 Q1 HEALTH CARE SCIENCES & SERVICES Pub Date : 2024-06-01 Epub Date: 2024-04-26 DOI: 10.1097/MLR.0000000000002002
Diana Montoya-Williams, Alejandra Barreto, Alicia Laguna-Torres, Diana Worsley, Kate Wallis, Michelle-Marie Peña, Lauren Palladino, Nicole Salva, Lisa Levine, Angelique Rivera, Rosalinda Hernandez, Elena Fuentes-Afflick, Katherine Yun, Scott Lorch, Senbagam Virudachalam

Research design: Community-engaged qualitative study using inductive thematic analysis of semistructured interviews.

Objective: To understand Latine immigrants' recent prenatal care experiences and develop community-informed strategies to mitigate policy-related chilling effects on prenatal care utilization.

Background: Decreased health care utilization among immigrants due to punitive immigration policies (ie, the "chilling effect") has been well-documented among Latine birthing people both pre and postnatally.

Patients and methods: Currently or recently pregnant immigrant Latine people in greater Philadelphia were recruited from an obstetric clinic, 2 pediatric primary care clinics, and 2 community-based organization client pools. Thematic saturation was achieved with 24 people. Participants' pregnancy narratives and their perspectives on how health care providers and systems could make prenatal care feel safer and more comfortable for immigrants.

Results: Participants' recommendations for mitigating the chilling effect during the prenatal period included training prenatal health care providers to sensitively initiate discussions about immigrants' rights and reaffirm confidentiality around immigration status. Participants suggested that health care systems should expand sources of information for pregnant immigrants, either by partnering with community organizations to disseminate information or by increasing access to trusted individuals knowledgeable about immigrants' rights to health care. Participants also suggested training non-medical office staff in the use of interpreters.

Conclusion: Immigrant Latine pregnant and birthing people in greater Philadelphia described ongoing fear and confusion regarding the utilization of prenatal care, as well as experiences of discrimination. Participants' suggestions for mitigating immigration-related chilling effects can be translated into potential policy and programmatic interventions which could be implemented locally and evaluated for broader applicability.

研究设计:研究设计:社区参与的定性研究,采用归纳式主题分析法对半结构式访谈进行分析:了解拉丁裔移民最近的产前护理经历,并制定社区知情策略,以减轻与政策相关的产前护理利用率寒蝉效应:背景:由于惩罚性移民政策(即 "寒蝉效应")而导致的移民医疗保健利用率下降在拉丁裔分娩者产前和产后都有大量记录:从一家产科诊所、两家儿科初级保健诊所和两家社区组织的客户群中招募了大费城地区目前或近期怀孕的拉丁裔移民。有 24 人达到了主题饱和。参与者的怀孕叙述以及他们对医疗服务提供者和系统如何使移民产前护理更安全、更舒适的看法:结果:与会者提出的减轻产前寒蝉效应的建议包括培训产前保健提供者,以敏感的方式就移民权利展开讨论,并重申对移民身份保密。与会者建议,医疗保健系统应扩大怀孕移民的信息来源,与社区组织合作传播信息,或增加接触了解移民医疗保健权利的可信个人的机会。与会者还建议对非医务人员进行使用翻译的培训:大费城地区的拉丁裔怀孕和分娩移民描述了在使用产前护理方面持续存在的恐惧和困惑,以及遭受歧视的经历。参与者提出的减轻与移民有关的寒蝉效应的建议可以转化为潜在的政策和计划干预措施,这些措施可以在当地实施,并进行评估以扩大适用性。
{"title":"Philadelphia Latine Immigrant Birthing People's Perspectives on Mitigating the Chilling Effect on Prenatal Care Utilization.","authors":"Diana Montoya-Williams, Alejandra Barreto, Alicia Laguna-Torres, Diana Worsley, Kate Wallis, Michelle-Marie Peña, Lauren Palladino, Nicole Salva, Lisa Levine, Angelique Rivera, Rosalinda Hernandez, Elena Fuentes-Afflick, Katherine Yun, Scott Lorch, Senbagam Virudachalam","doi":"10.1097/MLR.0000000000002002","DOIUrl":"10.1097/MLR.0000000000002002","url":null,"abstract":"<p><strong>Research design: </strong>Community-engaged qualitative study using inductive thematic analysis of semistructured interviews.</p><p><strong>Objective: </strong>To understand Latine immigrants' recent prenatal care experiences and develop community-informed strategies to mitigate policy-related chilling effects on prenatal care utilization.</p><p><strong>Background: </strong>Decreased health care utilization among immigrants due to punitive immigration policies (ie, the \"chilling effect\") has been well-documented among Latine birthing people both pre and postnatally.</p><p><strong>Patients and methods: </strong>Currently or recently pregnant immigrant Latine people in greater Philadelphia were recruited from an obstetric clinic, 2 pediatric primary care clinics, and 2 community-based organization client pools. Thematic saturation was achieved with 24 people. Participants' pregnancy narratives and their perspectives on how health care providers and systems could make prenatal care feel safer and more comfortable for immigrants.</p><p><strong>Results: </strong>Participants' recommendations for mitigating the chilling effect during the prenatal period included training prenatal health care providers to sensitively initiate discussions about immigrants' rights and reaffirm confidentiality around immigration status. Participants suggested that health care systems should expand sources of information for pregnant immigrants, either by partnering with community organizations to disseminate information or by increasing access to trusted individuals knowledgeable about immigrants' rights to health care. Participants also suggested training non-medical office staff in the use of interpreters.</p><p><strong>Conclusion: </strong>Immigrant Latine pregnant and birthing people in greater Philadelphia described ongoing fear and confusion regarding the utilization of prenatal care, as well as experiences of discrimination. Participants' suggestions for mitigating immigration-related chilling effects can be translated into potential policy and programmatic interventions which could be implemented locally and evaluated for broader applicability.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Electronic Information Exchange Associated With Lower 30-Day Readmission Charges Among Medicare Beneficiaries? 电子信息交换是否会降低医疗保险受益人的 30 天再入院费用?
IF 3 2区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-04-10 DOI: 10.1097/MLR.0000000000002003
Sara D Turbow, Puneet K Chehal, Steven D Culler, Camille P Vaughan, Christina Offutt, Kimberly J Rask, Molly M Perkins, Carolyn K Clevenger, Mohammed K Ali

Objective: Fragmented readmissions, when admission and readmission occur at different hospitals, are associated with increased charges compared with nonfragmented readmissions. We assessed if hospital participation in health information exchange (HIE) was associated with differences in total charges in fragmented readmissions.

Data source: Medicare Fee-for-Service Data, 2018.

Study design: We used generalized linear models with hospital referral region and readmission month fixed effects to assess relationships between information sharing (same HIE, different HIEs, and no HIE available) and total charges of 30-day readmissions among fragmented readmissions; analyses were adjusted for patient-level clinical/demographic characteristics and hospital-level characteristics.

Data extraction methods: We included beneficiaries with a hospitalization for acute myocardial infarction, congestive heart failure, chronic obstructive pulmonary disease, syncope, urinary tract infection, dehydration, or behavioral issues with a 30-day readmission for any reason.

Principal findings: In all, 279,729 admission-readmission pairs were included, 27% of which were fragmented (n=75,438); average charges of fragmented readmissions were $64,897-$71,606. Compared with fragmented readmissions where no HIE was available, the average marginal effects of same-HIE and different-HIE admission-readmission pairs were -$2329.55 (95% CI: -7333.73, 2674.62) and -$3905.20 (95% CI: -7592.85, -307.54), respectively. While the average marginal effects of different-HIE pairs were lower than those for no-HIE fragmented readmissions, the average marginal effects of same-HIE and different-HIE pairs were not significantly different from each other.

Conclusions: There were no statistical differences in charges between fragmented readmissions to hospitals that share an HIE or that do not share an HIE compared with hospitals with no HIE available.

目的:当入院和再入院发生在不同的医院时,与非碎片化再入院相比,碎片化再入院会导致费用增加。我们评估了医院参与健康信息交换(HIE)是否与碎片化再入院的总费用差异有关:医疗保险付费服务数据,2018.研究设计:我们使用带有医院转诊地区和再入院月份固定效应的广义线性模型来评估信息共享(相同HIE、不同HIE和无HIE可用)与碎片化再入院中30天再入院总费用之间的关系;分析根据患者水平的临床/人口学特征和医院水平特征进行调整.数据提取方法:我们纳入了因急性心肌梗死、充血性心力衰竭、慢性阻塞性肺病、晕厥、尿路感染、脱水或行为问题而住院的受益人,并以任何原因进行了 30 天再入院治疗:共纳入 279,729 对入院-再入院病例,其中 27% 为零散入院病例(n=75,438);零散再入院病例的平均费用为 64,897 美元至 71,606 美元。与没有 HIE 的零散再入院相比,相同 HIE 和不同 HIE 入院-再入院对的平均边际效应分别为-2329.55 美元(95% CI:-7333.73, 2674.62)和-3905.20 美元(95% CI:-7592.85, -307.54)。虽然不同HIE对的平均边际效应低于无HIE碎片再入院的平均边际效应,但相同HIE和不同HIE对的平均边际效应没有显著差异:结论:与无 HIE 的医院相比,共享 HIE 或不共享 HIE 的医院的碎片再入院费用没有统计学差异。
{"title":"Is Electronic Information Exchange Associated With Lower 30-Day Readmission Charges Among Medicare Beneficiaries?","authors":"Sara D Turbow, Puneet K Chehal, Steven D Culler, Camille P Vaughan, Christina Offutt, Kimberly J Rask, Molly M Perkins, Carolyn K Clevenger, Mohammed K Ali","doi":"10.1097/MLR.0000000000002003","DOIUrl":"10.1097/MLR.0000000000002003","url":null,"abstract":"<p><strong>Objective: </strong>Fragmented readmissions, when admission and readmission occur at different hospitals, are associated with increased charges compared with nonfragmented readmissions. We assessed if hospital participation in health information exchange (HIE) was associated with differences in total charges in fragmented readmissions.</p><p><strong>Data source: </strong>Medicare Fee-for-Service Data, 2018.</p><p><strong>Study design: </strong>We used generalized linear models with hospital referral region and readmission month fixed effects to assess relationships between information sharing (same HIE, different HIEs, and no HIE available) and total charges of 30-day readmissions among fragmented readmissions; analyses were adjusted for patient-level clinical/demographic characteristics and hospital-level characteristics.</p><p><strong>Data extraction methods: </strong>We included beneficiaries with a hospitalization for acute myocardial infarction, congestive heart failure, chronic obstructive pulmonary disease, syncope, urinary tract infection, dehydration, or behavioral issues with a 30-day readmission for any reason.</p><p><strong>Principal findings: </strong>In all, 279,729 admission-readmission pairs were included, 27% of which were fragmented (n=75,438); average charges of fragmented readmissions were $64,897-$71,606. Compared with fragmented readmissions where no HIE was available, the average marginal effects of same-HIE and different-HIE admission-readmission pairs were -$2329.55 (95% CI: -7333.73, 2674.62) and -$3905.20 (95% CI: -7592.85, -307.54), respectively. While the average marginal effects of different-HIE pairs were lower than those for no-HIE fragmented readmissions, the average marginal effects of same-HIE and different-HIE pairs were not significantly different from each other.</p><p><strong>Conclusions: </strong>There were no statistical differences in charges between fragmented readmissions to hospitals that share an HIE or that do not share an HIE compared with hospitals with no HIE available.</p>","PeriodicalId":18364,"journal":{"name":"Medical Care","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11090414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1